Deutsch English Français

Contact

EP0917459

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0917459

EP0917459 - TABLET DOSAGE FORM OF CLAVULANIC ACID AND AMOXYCILLIN COMPRISING A TREHALOSE EXCIPIENT [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 28.05.2004 Database last updated on 28.09.2024
Most recent event Tooltip	28.05.2004	Application deemed to be withdrawn	published on 14.07.2004 [2004/29]
Applicant(s)	For all designated states Elan Drug Delivery Limited 1 Mere Way, Ruddington Nottingham, NG11 6JS / GB
	[2002/47]
Former [2002/02]	For all designated states Quadrant Healthcare (UK) Limited 1 Mere Way Ruddington, Nottingham NG11 6JS / GB
Former [2001/48]	For all designated states QUADRANT HEALTHCARE (UK) LIMITED Maris Lane Trumpington, Cambridge CB2 2SY / GB
Former [1999/21]	For all designated states QUADRANT HOLDINGS CAMBRIDGE LIMITED Maris Lane Trumpington, Cambridge CB2 2SY / GB
Inventor(s)	01 / GRIBBON, Enda, Martin 18 South Mill Road, Bishops Stortford Herts CM23 3DP / GB
	02 / MARTYN, Glen, Patrick 27 Ermine Street Caxton, Cambridgeshire CB3 8PQ / GB
	03 / COLACO, Camilo, Anthony, Leo, Selwyn 107 Foster Road Cambridge CB2 2JN / GB
	[1999/21]
Representative(s)	Perry, Robert Edward Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB
	[N/P]
Former [1999/32]	Perry, Robert Edward GILL JENNINGS & EVERY Broadgate House 7 Eldon Street London EC2M 7LH / GB
Former [1999/21]	Browne, Robin Forsythe, Dr. Urquhart-Dykes & Lord Tower House Merrion Way Leeds LS2 8PA West Yorkshire / GB
Application number, filing date	97934631.9	04.08.1997
	[1999/21]
	WO1997GB02083
Priority number, date	GB19960016536	06.08.1996 Original published format: GB 9616536
	[1999/21]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9805305
	Date:	12.02.1998
	Language:	EN
	[1998/06]
	Type:	A1 Application with search report
	No.:	EP0917459
	Date:	26.05.1999
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.02.1998 takes the place of the publication of the European patent application.
	[1999/21]
Search report(s)	International search report - published on:	EP	12.02.1998
Classification	IPC:	A61K9/20	[1999/21]
	CPC:	A61K9/2018 (EP,US)
Designated contracting states	AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1999/21]
Title	German:	CLAVULANSÄURE UND AMOXYCILLIN ENTHALTENDE TABLETTENDOSIERUNGSFORM MIT TREHALOSE ALS HILFSSTOFF	[1999/21]
	English:	TABLET DOSAGE FORM OF CLAVULANIC ACID AND AMOXYCILLIN COMPRISING A TREHALOSE EXCIPIENT	[1999/21]
	French:	FORME POSOLOGIQUE EN COMPRIME D'ACIDE CLAVULANIQUE ET D'AMOXICILLINE COMPORTANT UN EXCIPIENT A BASE DE TREHALOSE	[1999/21]
Entry into regional phase	23.02.1999	National basic fee paid
	23.02.1999	Designation fee(s) paid
	23.02.1999	Examination fee paid
Examination procedure	30.01.1998	Request for preliminary examination filed International Preliminary Examining Authority: EP
	23.02.1999	Examination requested [1999/21]
	08.07.1999	Despatch of a communication from the examining division (Time limit: M04)
	12.10.1999	Reply to a communication from the examining division
	23.11.2000	Despatch of a communication from the examining division (Time limit: M06)
	21.05.2001	Reply to a communication from the examining division
	11.08.2003	Despatch of a communication from the examining division (Time limit: M04)
	23.12.2003	Application deemed to be withdrawn, date of legal effect [2004/29]
	02.02.2004	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/29]
Fees paid	Renewal fee
	23.02.1999	Renewal fee patent year 03
	16.08.2000	Renewal fee patent year 04
	14.08.2001	Renewal fee patent year 05
	14.08.2002	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	31.08.2003	07 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]GB2005538 (BEECHAM GROUP LTD) [Y] 1,10,11,13,20,21 * page 1; examples 1,4; claims 1,2,5,6,9,11 *;
		[A]WO8700196 (QUADRANT BIORESOURCES LTD [GB]) [A] 1 * page 2, paragraphs 2-3; claims 1,8-10 *;
		[Y]US4678812 (BOLLIN JR ERNEST [US], et al) [Y] 1,6,10,11,13,17,20,21 * column 2, lines 42-54; claim 1 * * column 3, lines 31-34 * * column 4, lines 6-8 * * column 4, lines 33-45 *;
		[A]GB2206273 (QUADRANT BIORESOURCES LTD) [A] 1 * page 3, paragraph 4; claims 1,2,4 * * page 4, paragraphs 2-3 *;
		[Y]EP0415567 (QUADRANT BIORESOURCES LTD [GB]) [Y] 1 * page 2, lines 8-13 * * page 2, lines 21-22 * * page 2, lines 49-55; claims 4,7-10,13,14 *;
		[DA]WO9219227 (SMITHKLINE BEECHAM PLC [GB], et al) [DA] 1,10-13,17-19 * page 2, paragraphs 2-3; examples 9-14 * * page 3, paragraph 4; claims 1-6 * * page 4, paragraphs 3-4; claims 8-17 *;
		[A]WO9222298 (UNGER EVAN C [US], et al) [A] 1 * page 12, lines 21-23 * * page 20, lines 26-36 *;
		[Y]EP0664117 (HOFFMANN LA ROCHE [CH]) [Y] 1,6,10,11,13,17,20,21 * page 2, line 16; claims 1,2 * * page 3, lines 50-56; claims 3,8,10 *;
		[DY]WO9528927 (SMITHKLINE BEECHAM CORP [US], et al) [DY] 1,6,10,11,13,17,20 * page 2, lines 20-33; example 1; claims 1,2,4,5 * * page 3, lines 9-13 * * page 1, lines 16-22 * * page 1, lines 29-32 *;
		[Y]EP0693558 (HAYASHIBARA BIOCHEM LAB [JP]) [Y] 1,6,10,11,13,17,20,21 * page 8, lines 8-13 * * page 8, line 52 - page 9, line 1 *;
		[A]WO9622107 (QUADRANT HOLDINGS CAMBRIDGE [GB], et al) [A] 1* page 1, paragraph 4 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p